DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Structures of human ENT1 in complex with adenosine reuptake inhibitors

Journal Article · · Nature Structural & Molecular Biology

The human equilibrative nucleoside transporter 1 (hENT1), a member of the SLC29 family, plays crucial roles in adenosine signaling, cellular uptake of nucleoside for DNA and RNA synthesis, and nucleoside-derived anticancer and antiviral drug transport in humans. Because of its central role in adenosine signaling, it is the target of adenosine reuptake inhibitors (AdoRI), several of which are used clinically. Despite its importance in human physiology and pharmacology, the molecular basis of hENT1-mediated adenosine transport and its inhibition by AdoRIs are limited, owing to the absence of structural information on hENT1. As such, here, we present crystal structures of hENT1 in complex with two chemically distinct AdoRIs: dilazep and S-(4-nitrobenzyl)-6-thioinosine (NBMPR). Combined with mutagenesis study, our structural analyses elucidate two distinct inhibitory mechanisms exhibited on hENT1 and provide insight into adenosine recognition and transport. Our studies provide a platform for improved pharmacological intervention of adenosine and nucleoside analog drug transport by hENT1.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
National Institutes of Health (NIH)
OSTI ID:
1544863
Journal Information:
Nature Structural & Molecular Biology, Journal Name: Nature Structural & Molecular Biology Journal Issue: 7 Vol. 26; ISSN 1545-9993
Publisher:
Nature Publishing GroupCopyright Statement
Country of Publication:
United States
Language:
ENGLISH

References (101)

Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer journal July 2010
Nucleoside transport in rat erythrocytes: two components with differences in sensitivity to inhibition by nitrobenzylthioinosine andp-chloromercuriphenyl sulfonate journal February 1986
Functional characterization of human equilibrative nucleoside transporter 1 journal December 2016
Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep journal February 2004
The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29 journal April 2013
Fluorescence-Detection Size-Exclusion Chromatography for Precrystallization Screening of Integral Membrane Proteins journal April 2006
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? journal June 2016
Nucleoside transporters: molecular biology and implications for therapeutic development journal May 1999
Synthesis, Flow Cytometric Evaluation, and Identification of Highly Potent Dipyridamole Analogues as Equilibrative Nucleoside Transporter 1 Inhibitors journal August 2007
Crystal structure of a concentrative nucleoside transporter from Vibrio cholerae at 2.4 Å journal March 2012
X-ray structure of dopamine transporter elucidates antidepressant mechanism journal September 2013
Crystal structure of the human glucose transporter GLUT1 journal May 2014
X-ray structures and mechanism of the human serotonin transporter journal April 2016
Visualizing multistep elevator-like transitions of a nucleoside transporter journal April 2017
The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference journal July 2004
Understanding transport by the major facilitator superfamily (MFS): structures pave the way journal January 2016
Serotonin transporter–ibogaine complexes illuminate mechanisms of inhibition and transport journal April 2019
Mutation of leucine-92 selectively reduces the apparent affinity of inosine, guanosine, NBMPR [S6-(4-nitrobenzyl)-mercaptopurine riboside] and dilazep for the human equilibrative nucleoside transporter, hENT1 journal May 2004
Mutation of Trp29 of human equilibrative nucleoside transporter 1 alters affinity for coronary vasodilator drugs and nucleoside selectivity journal August 2008
Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer journal January 2009
Dipyridamole journal May 1987
Lipidic cubic phases: A novel concept for the crystallization of membrane proteins journal December 1996
Mutation of Residue 33 of Human Equilibrative Nucleoside Transporters 1 and 2 Alters Sensitivity to Inhibition of Transport by Dilazep and Dipyridamole journal October 2001
Topology of a Human Equilibrative, Nitrobenzylthioinosine (NBMPR)-sensitive Nucleoside Transporter (hENT1) Implicated in the Cellular Uptake of Adenosine and Anti-cancer Drugs journal October 2001
Residues 334 and 338 in Transmembrane Segment 8 of Human Equilibrative Nucleoside Transporter 1 Are Important Determinants of Inhibitor Sensitivity, Protein Folding, and Catalytic Turnover journal March 2007
Equilibrative nucleoside transporters—A review journal October 2016
Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial journal December 2013
Substructure solution with SHELXD journal September 2002
XDS journal January 2010
iMOSFLM : a new graphical interface for diffraction-image processing with MOSFLM journal March 2011
REFMAC 5 for the refinement of macromolecular crystal structures journal March 2011
Experimental phasing for structure determination using membrane-protein crystals grown by the lipid cubic phase method journal January 2015
Erythrocyte nucleoside transport: asymmetrical binding of nitrobenzylthioinosine to nucleoside permeation sites journal March 1982
Residue 33 of Human Equilibrative Nucleoside Transporter 2 Is a Functionally Important Component of Both the Dipyridamole and Nucleoside Binding Sites journal January 2005
Residues Met89 and Ser160 in the Human Equilibrative Nucleoside Transporter 1 Affect Its Affinity for Adenosine, Guanosine, S 6 -(4-Nitrobenzyl)-mercaptopurine Riboside, and Dipyridamole journal November 2004
Structure and Mechanism of the Lactose Permease of Escherichia coli journal August 2003
The Absence of Human Equilibrative Nucleoside Transporter 1 Is Associated with Reduced Survival in Patients With Gemcitabine-Treated Pancreas Adenocarcinoma journal October 2004
Human Equilibrative Nucleoside Transporter 1 and Human Concentrative Nucleoside Transporter 3 Predict Survival after Adjuvant Gemcitabine Therapy in Resected Pancreatic Adenocarcinoma journal April 2009
The Role of Flexible Loops in Folding, Trafficking and Activity of Equilibrative Nucleoside Transporters journal September 2015
Interdependence of Gemcitabine Treatment, Transporter Expression, and Resistance in Human Pancreatic Carcinoma Cells journal September 2010
PHENIX: a comprehensive Python-based system for macromolecular structure solution. text January 2010
Nucleoside Transporter Proteins journal October 2009
Molecular predictors of gemcitabine response in pancreatic cancer journal January 2011
Structural basis of nucleoside and nucleoside drug selectivity by concentrative nucleoside transporters journal July 2014
Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer journal July 2010
Energy coupling mechanisms of MFS transporters: Energy Coupling Mechanisms of MFS Transporters journal September 2015
Nucleoside transport in rat erythrocytes: two components with differences in sensitivity to inhibition by nitrobenzylthioinosine andp-chloromercuriphenyl sulfonate journal February 1986
Functional characterization of human equilibrative nucleoside transporter 1 journal December 2016
Adenosine, adenosine receptors and myocardial protection An updated overview journal October 2001
Nucleoside transporters: molecular biology and implications for therapeutic development journal May 1999
Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep journal February 2004
CoMFA and CoMSIA 3D-QSAR studies on S6-(4-nitrobenzyl)mercaptopurine riboside (NBMPR) analogs as inhibitors of human equilibrative nucleoside transporter 1 (hENT1) journal January 2009
The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29 journal April 2013
Fluorescence-Detection Size-Exclusion Chromatography for Precrystallization Screening of Integral Membrane Proteins journal April 2006
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? journal June 2016
Synthesis, Flow Cytometric Evaluation, and Identification of Highly Potent Dipyridamole Analogues as Equilibrative Nucleoside Transporter 1 Inhibitors journal August 2007
X-ray structures of LeuT in substrate-free outward-open and apo inward-open states journal January 2012
Crystal structure of a concentrative nucleoside transporter from Vibrio cholerae at 2.4 Å journal March 2012
X-ray structure of dopamine transporter elucidates antidepressant mechanism journal September 2013
Crystal structure of the human glucose transporter GLUT1 journal May 2014
Molecular basis of ligand recognition and transport by glucose transporters journal July 2015
Structure and mechanism of the mammalian fructose transporter GLUT5 journal September 2015
X-ray structures and mechanism of the human serotonin transporter journal April 2016
Visualizing multistep elevator-like transitions of a nucleoside transporter journal April 2017
Cloning of a human nucleoside transporter implicated in the Cellular uptake of adenosine and chemotherapeutic drugs journal January 1997
The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference journal July 2004
Screening and large-scale expression of membrane proteins in mammalian cells for structural studies journal October 2014
Understanding transport by the major facilitator superfamily (MFS): structures pave the way journal January 2016
Rapamycin-inspired macrocycles with new target specificity journal December 2018
Role of cysteine 416 in N-ethylmaleimide sensitivity of human equilibrative nucleoside transporter 1 (hENT1) journal October 2018
Mutation of Trp29 of human equilibrative nucleoside transporter 1 alters affinity for coronary vasodilator drugs and nucleoside selectivity journal August 2008
Mutation of leucine-92 selectively reduces the apparent affinity of inosine, guanosine, NBMPR [S6-(4-nitrobenzyl)-mercaptopurine riboside] and dilazep for the human equilibrative nucleoside transporter, hENT1 journal May 2004
Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer journal January 2009
Dipyridamole journal May 1987
Lipidic cubic phases: A novel concept for the crystallization of membrane proteins journal December 1996
Mutation of Residue 33 of Human Equilibrative Nucleoside Transporters 1 and 2 Alters Sensitivity to Inhibition of Transport by Dilazep and Dipyridamole journal October 2001
Topology of a Human Equilibrative, Nitrobenzylthioinosine (NBMPR)-sensitive Nucleoside Transporter (hENT1) Implicated in the Cellular Uptake of Adenosine and Anti-cancer Drugs journal October 2001
Functional Analysis of an Inosine-Guanosine Transporter from Leishmania donovani : THE ROLE OF CONSERVED RESIDUES, ASPARTATE 389 AND ARGININE 393 journal June 2003
Identification and Mutational Analysis of Amino Acid Residues Involved in Dipyridamole Interactions with Human and Caenorhabditis elegans Equilibrative Nucleoside Transporters journal January 2005
Residues 334 and 338 in Transmembrane Segment 8 of Human Equilibrative Nucleoside Transporter 1 Are Important Determinants of Inhibitor Sensitivity, Protein Folding, and Catalytic Turnover journal March 2007
Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins journal August 2008
Equilibrative nucleoside transporters—A review journal October 2016
Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial journal December 2013
Substructure solution with SHELXD journal September 2002
XDS journal January 2010
iMOSFLM : a new graphical interface for diffraction-image processing with MOSFLM journal March 2011
REFMAC 5 for the refinement of macromolecular crystal structures journal March 2011
Experimental phasing for structure determination using membrane-protein crystals grown by the lipid cubic phase method journal January 2015
Erythrocyte nucleoside transport: asymmetrical binding of nitrobenzylthioinosine to nucleoside permeation sites journal March 1982
Residue 33 of Human Equilibrative Nucleoside Transporter 2 Is a Functionally Important Component of Both the Dipyridamole and Nucleoside Binding Sites journal January 2005
Residues Met89 and Ser160 in the Human Equilibrative Nucleoside Transporter 1 Affect Its Affinity for Adenosine, Guanosine, S 6 -(4-Nitrobenzyl)-mercaptopurine Riboside, and Dipyridamole journal November 2004
Structure and Mechanism of the Lactose Permease of Escherichia coli journal August 2003
A Competitive Inhibitor Traps LeuT in an Open-to-Out Conformation journal December 2008
The Absence of Human Equilibrative Nucleoside Transporter 1 Is Associated with Reduced Survival in Patients With Gemcitabine-Treated Pancreas Adenocarcinoma journal October 2004
Human Equilibrative Nucleoside Transporter 1 and Human Concentrative Nucleoside Transporter 3 Predict Survival after Adjuvant Gemcitabine Therapy in Resected Pancreatic Adenocarcinoma journal April 2009
The Role of Flexible Loops in Folding, Trafficking and Activity of Equilibrative Nucleoside Transporters journal September 2015
Interdependence of Gemcitabine Treatment, Transporter Expression, and Resistance in Human Pancreatic Carcinoma Cells journal September 2010
Nucleoside Transport Inhibitors: Structure-Activity Relationships and Potential Therapeutic Applications journal February 1997
Nucleoside Transporter Proteins journal October 2009
Molecular predictors of gemcitabine response in pancreatic cancer journal January 2011
Structural basis of nucleoside and nucleoside drug selectivity by concentrative nucleoside transporters journal July 2014

Cited By (4)

Adenosine Receptor Profiling Reveals an Association between the Presence of Spare Receptors and Cardiovascular Disorders journal November 2019
The genetic landscape of the human solute carrier (SLC) transporter superfamily journal November 2019
Current Progress on Equilibrative Nucleoside Transporter Function and Inhibitor Design journal September 2019
Adenosine Receptor Profiling Reveals an Association between the Presence of Spare Receptors and Cardiovascular Disorders journal November 2019